Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1081

    1.

    Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary.

    Yavelsky V, Rohkin S, Shaco-Levy R, Tzikinovsky A, Amir T, Kohn H, Delgado B, Rabinovich A, Piura B, Chan G, Kalantarov G, Trakht I, Lobel L.

    BMC Cancer. 2008 Aug 24;8:247.PMID: 18721484 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A human monoclonal autoantibody to breast cancer identifies the PDZ domain containing protein GIPC1 as a novel breast cancer-associated antigen.

    Rudchenko S, Scanlan M, Kalantarov G, Yavelsky V, Levy C, Estabrook A, Old L, Chan GL, Lobel L, Trakht I.

    BMC Cancer. 2008 Aug 24;8:248.PMID: 18721486 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.

    Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, Gupta A, Suri A.

    Clin Cancer Res. 2007 Mar 1;13(5):1421-8.PMID: 17332284 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Enhancer of the rudimentary gene homologue (ERH) expression pattern in sporadic human breast cancer and normal breast tissue.

    Zafrakas M, Losen I, Knüchel R, Dahl E.

    BMC Cancer. 2008 May 23;8:145.PMID: 18500978 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells.

    Xu FJ, Yu YH, Li BY, Moradi M, Elg S, Lane C, Carson L, Ramakrishnan S.

    Cancer Res. 1991 Aug 1;51(15):4012-9.PMID: 1855217 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study.

    Honig A, Rieger L, Kapp M, Krockenberger M, Eck M, Dietl J, Kämmerer U.

    BMC Cancer. 2006 Jul 25;6:199.PMID: 16869970 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.

    Borgoño CA, Grass L, Soosaipillai A, Yousef GM, Petraki CD, Howarth DH, Fracchioli S, Katsaros D, Diamandis EP.

    Cancer Res. 2003 Dec 15;63(24):9032-41.PMID: 14695222 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes.

    Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, Simkins S, Xu L.

    Clin Cancer Res. 2000 Jun;6(6):2417-23.PMID: 10873094 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Chemiluminescent optical fiber immunosensor for detection of autoantibodies to ovarian and breast cancer-associated antigens.

    Salama O, Herrmann S, Tziknovsky A, Piura B, Meirovich M, Trakht I, Reed B, Lobel LI, Marks RS.

    Biosens Bioelectron. 2007 Feb 15;22(7):1508-16. Epub 2006 Aug 9.PMID: 16904309 [PubMed - indexed for MEDLINE]Related articles

    10.

    Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines.

    Hunakova L, Bodo J, Chovancova J, Sulikova G, Pastorekova S, Sedlak J.

    Neoplasma. 2007;54(6):541-8.PMID: 17949239 [PubMed - indexed for MEDLINE]Related articles

    11.

    HLA-G is a potential tumor marker in malignant ascites.

    Singer G, Rebmann V, Chen YC, Liu HT, Ali SZ, Reinsberg J, McMaster MT, Pfeiffer K, Chan DW, Wardelmann E, Grosse-Wilde H, Cheng CC, Kurman RJ, Shih IeM.

    Clin Cancer Res. 2003 Oct 1;9(12):4460-4.PMID: 14555519 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.

    Litkouhi B, Litkouhi B, Fleming E, Welch WR, Berkowitz RS, Birrer MJ, Mok SC.

    Gynecol Oncol. 2008 May;109(2):234-9. Epub 2008 Mar 10.PMID: 18331757 [PubMed - indexed for MEDLINE]Related articles

    13.

    Isolation of native human monoclonal autoantibodies to breast cancer.

    Kirman I, Kalantarov GF, Lobel LI, Hibshoosh H, Estabrook A, Canfield R, Trakht I.

    Hybrid Hybridomics. 2002 Dec;21(6):405-14.PMID: 12573104 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.

    Zagorianakou N, Stefanou D, Makrydimas G, Zagorianakou P, Briasoulis E, Karavasilis V, Pavlidis N, Agnantis NJ.

    Histol Histopathol. 2006 Apr;21(4):341-7.PMID: 16437378 [PubMed - indexed for MEDLINE]Related articles

    15.

    Expression of human GIPC1 in normal tissues, cancer cell lines, and primary tumors.

    Kirikoshi H, Katoh M.

    Int J Mol Med. 2002 May;9(5):509-13.PMID: 11956658 [PubMed - indexed for MEDLINE]Related articles

    16.
    17.

    The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.

    Wang P, Wu X, Chen W, Liu J, Wang X.

    Gynecol Oncol. 2007 Mar;104(3):714-20. Epub 2007 Jan 3.PMID: 17204312 [PubMed - indexed for MEDLINE]Related articles

    18.

    GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer.

    Rudlowski C, Moser M, Becker AJ, Rath W, Buttner R, Schroder W, Schurmann A.

    Oncology. 2004;66(5):404-10.PMID: 15331928 [PubMed - indexed for MEDLINE]Related articles

    19.

    Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition.

    Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, Thompson EW, Quinn MA, Rice GE.

    Int J Cancer. 2007 Jun 1;120(11):2426-34.PMID: 17294443 [PubMed - indexed for MEDLINE]Related articles

    20.

    Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry.

    Bonsing BA, Corver WE, Gorsira MC, van Vliet M, Oud PS, Cornelisse CJ, Fleuren GJ.

    Cytometry. 1997 May 1;28(1):11-24.PMID: 9136751 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination